Dallas, TX -- (SBWIRE) -- 05/01/2015 -- Browse 99 market data tables and 44 figures spread through 280 pages and in-depth TOC on "Life Science and Chemical Instrumentation Market"

http://www.marketsandmarkets.com/Market-Reports/life-science-chemical-biotech-instrumentation-market-38.html

Early buyers will receive 10% customization on this report.

This report studies the global life science and chemical instrumentation market over the forecast period of 2014 to 2019. The market is expected to reach $48.84 billion by 2019, at CAGR of 6.9% from 2014 to 2019.

Based on the technology, the global life science and chemical instrumentation market is divided into nine major segments, namely, chromatography (liquid, gas, and others), electrophoresis (gel and capillary), DNA sequencers and amplifiers (thermal cyclers, real-time PCR, and others), lab automation (automated liquid handling, microplate readers, robots, automated storage & retrieval systems, software & informatics, and others), spectroscopy (molecular, atomic, and mass), immunoassay (enzyme, chemiluminescence, radioimmunoassay, fluorescence, and others), microarray (DNA, protein, cell, and tissue), flow cytometry (cell-based, bead-based, and others), and other instruments (centrifuges, laboratory balances, incubators, and fume hoods).

The report also segments the global life science and chemical instrumentation market by end user. The major end users of this market include pharmaceutical, biopharmaceutical, and biotechnology companies; clinical research organizations (CROs); research institutions; hospitals, clinics, and diagnostic laboratories; academic institutions; forensic science laboratories; food and agriculture industry; and environmental testing industry; among others

Inquiry before Buying: www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=38

A number of factors such as growing pharmaceutical R&D in emerging nations, rising food safety concerns, availability of public and private funding for life science research, and continuous technological advancements in analytical instruments are fuelling the demand of life science and chemical instrumentations. On the other hand, presence of alternative analytical technologies, high cost of instruments, and need of skilled professionals are some of the key factors limiting the growth of the global life science and chemical instrumentation market.

As of 2014, North America held the largest share of the global life science and chemical instrumentation market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest rate during the forecast period. A number of factors including strategic expansion by key market players in emerging Asian countries; growing pharmaceutical industry in India and China; increasing government investment in biomedical industry in China and Singapore; and conferences, exhibitions, and meetings hosted by Asia-Pacific region on analytical instruments to increase the business relation are stimulating the growth of the life science and chemical instrumentation market in the Asia-Pacific region. However, factors such as scarcity of skilled life science researchers capable of operating highly sophisticated analytical systems and availability of limited financial budgets with the small- and medium-sized private research institutions and academic organizations restrict the demand of high-cost technologically advanced analytical instruments in this region.

You can speak To Research Analyst to know more about Report:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=38

Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.) are some of the key players operating in the global life science and chemical instrumentation market.

About MarketsandMarkets
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain
http://www.marketsandmarkets.com/Subscription.html

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: 888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets